Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Anna Forsythe's publication output changed over time?
ScholarIQpublication output · 2010–2022
Output declined50% over the shown period — from 2 works in 2010 to 1 in 2022.
2
1
1
1
3
2
1
2010201220132015202020212022
What are the most-cited papers on Anna Forsythe?
ScholarIQmost cited works
Chronic gout: epidemiology, disease progression, treatment and disease burden
Richard A. Brook, Anna Forsythe, James E. Smeeding, N. Lawrence Edwards
Current Medical Research and Opinion. 2010119 Citations
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors
Anna Forsythe, Wei Zhang, U.P. Strauss, Marc Fellous, Maesumeh Korei, Karen Keating
S41085503. 202099 CitationsOPEN ACCESS
Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy
N. Lawrence Edwards, John S. Sundy, Anna Forsythe, Steven W. Blume, Faming Pan, Michael A. Becker
Journal of Medical Economics. 201096 CitationsOPEN ACCESS
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Javier Cortés, Stacie Hudgens, Chris Twelves, Edith A. Perez, Ahmad Awada, Louise Yelle, Susan McCutcheon, Peter A. Kaufman, Anna Forsythe, Galina Velikova
Breast Cancer Research and Treatment. 201574 CitationsOPEN ACCESS
Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials
Vibeke Strand, Dinesh Khanna, Jasvinder A. Singh, Anna Forsythe, N. Lawrence Edwards
The Journal of Rheumatology. 201273 CitationsOPEN ACCESS
Related on ScholarIQ
Mercy Hospital for Women
Institution
Chronic gout: epidemiology, disease progression, treatment and disease burden
Paper
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors
Paper
Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy
Paper
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Paper
Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials
Paper